Whitepaper
26 Aug 2020

Sacubitril/Valsartan (LCZ696) Whitepaper

PDF 1.4 MB
Download

This whitepaper outlines Dr. Reddy’s development and characterization approach for the API and how formulation success and early market reach can be facilitated.

Content provided by our supplier

Dr. Reddy's Laboratories SA

  • CH
  • 2015
    On CPHI since
  • 3
    Certificates
  • 5000+
    Employees
Company types
Generics/Biosimilars Manufacturer
Primary activities
API Producer
Chemical Development
Generic APIs producer
Pharmaceutical Company (generic finished products)
View company profile

Other Content from Dr. Reddy's Laboratories SA (2)

  • Pharma Explained: Active Pharmaceutical Ingredients

    News Pharma Explained: Active Pharmaceutical Ingredients

    What are APIs? As the name suggests, Active Pharmaceutical Ingredients (APIs) are the heart of any dosage form, whether they are oral, injectable or inhaled, and are absolutely essential to the development of a formulated product.
    11 Mar 2021
  • Sugammadex Sodium API article

    Brochure Sugammadex Sodium API article

    Sugammadex sodium is one of the key molecules in Dr. Reddy’s API portfolio and an ideal use case on how a thorough understanding of the interaction between API and formulation can significantly improve the robustness of the formulation process considering the drug substance’s proneness to degradation in the formulation process, specifically during the terminal sterilization (TS) process for intravenous injection.